Cointime

Immunochina

company

About

Immunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development.

  • 1 - 10

Highlights

Total Funding Amount
¥140M $7.50M
Funding Rounds
3
Investors
4

Details

Last Funding Type
Series C
Last Funding Money Raised
¥140M
Industries
Biotechnology,Clinical Trials,Medical,Medical Device,Pharmaceutical
Founded date
Apr 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
¥140M $7.50M
Immunochina has raised a total of ¥140M $7.50M in funding over 2 rounds. Their latest funding was raised on Nov 24, 2021 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 24, 2021 Series D — 1 — — Detail
Jan 22, 2019 Series C ¥140M 2 Qingzhe Capital
China-Belgium Direct Equity Investment Fund 		— Detail
Nov 24, 2017 Series B $7.50M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
2
4
Immunochina is funded by 4 investors. Qingzhe Capital and China-Belgium Direct Equity Investment Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Qingzhe Capital Yes Series C
China-Belgium Direct Equity Investment Fund Yes Series C
Yajie Shanghui — Series D
ShengJing360 — Series B
Cointime
เนื้อหา
บริษัท